基本信息
views: 461
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
RESEARCH HIGHLIGHTS
successfully completed ‘first in man’ Phase I clinical trials on adoptive immunotherapy for recurrent and primary glioblastoma (GBM) and nasopharyngeal carcinoma (NPC) – PMID: 22282657; PMID: 28344888; PMID: 22282657; PMID: 22282657
successfully completed Phase I clinical trial on adoptive immunotherapy for drug-resistant CMV infection in solid organ transplant patients (funded by NHMRC) – PMID: 22282657; PMID: 22282657
developed a novel T cell therapy for progressive multiple sclerosis – PMID: 22282657
awarded international patents which have been licensed to national and international pharma/biotech companies
commercial launch of a QuantiFERON-CMV immune monitoring kit developed with our IP
major advance in CMV vaccine program with funding through NHMRC Development grant
attracted more than $8.15 m in research funding from various national and international funding agencies in last five years
selected as Queensland’s top 50 ‘Best and Brightest’ November 2014
elected as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS)
successfully completed ‘first in man’ Phase I clinical trials on adoptive immunotherapy for recurrent and primary glioblastoma (GBM) and nasopharyngeal carcinoma (NPC) – PMID: 22282657; PMID: 28344888; PMID: 22282657; PMID: 22282657
successfully completed Phase I clinical trial on adoptive immunotherapy for drug-resistant CMV infection in solid organ transplant patients (funded by NHMRC) – PMID: 22282657; PMID: 22282657
developed a novel T cell therapy for progressive multiple sclerosis – PMID: 22282657
awarded international patents which have been licensed to national and international pharma/biotech companies
commercial launch of a QuantiFERON-CMV immune monitoring kit developed with our IP
major advance in CMV vaccine program with funding through NHMRC Development grant
attracted more than $8.15 m in research funding from various national and international funding agencies in last five years
selected as Queensland’s top 50 ‘Best and Brightest’ November 2014
elected as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS)
Research Interests
Papers共 316 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bloodno. 1 (2024): 2-4
Paulo Martins, Rochelle C J D'Souza, Niclas Skarne,Lea Lekieffre,Shane Horsefield, Madusha Ranjankumar, Xiang Li,Thuy T Le,Fiona Smith,Corey Smith,Jacqueline Burrows,Bryan W Day,
Journal for immunotherapy of cancerno. 8 (2024)
ImmunoHorizonsno. 6 (2023): 508-527
Cytotherapyno. 6 (2023): S211-S212
Corey Smith,Janice Tsang,Leone Beagley, Daniel Chua, Victor Lee, Vivian Li, Denis J. Moss,William Coman, Kwok H. Chan, John Nicholls, Dora Kwong,Rajiv Khanna
crossref(2023)
NEUROLOGYno. 17 (2023)
crossref(2023)
ISCIENCEno. 12 (2023): 108474-108474
Load More
Author Statistics
#Papers: 314
#Citation: 14780
H-Index: 65
G-Index: 110
Sociability: 7
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn